HOME Top Market Reports Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020

Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: March 2015
Report Code: MD 3258

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The protein engineering market is estimated to grow at a CAGR of 15.7% to reach $1,463.0 million by 2020.

In this report, the global protein engineering market is broadly segmented by product, technology, end user, and region. By product, the market is categorized into instruments, reagents, and services and software.

On the basis of technology, the market is categorized into rational protein design, and irrational protein design. Rational protein design emerged as highly adopted technology in protein engineering market in 2014. This large share can be attributed to its advantages over irrational protein design technology.

Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietins, interferons, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies is the largest as well as fastest growing segment of the protein engineering protein type market. This growth is attributed to the increase in adoption of them for various therapies such as cancer and autoimmune diseases.

Based on end user, the protein engineering market is broadly classified into academic research institutes, pharmaceutical and biotechnology companies, and contract research organizations. Pharmaceutical and biotechnology companies is the largest and fastest-growing segment. The high growth rate of this market can be attributed to technological advancements in protein engineering and the increase in R&D budgets in the pharmaceutical sector.

Growth of this market is propelled by increase in adoption of protein drugs over non-protein drugs, high prevalence rate of lifestyle diseases, growth in funding for protein engineering and reduction in overall timeline and cost for drug discovery.  However, expensive and high maintenance tools and instruments used in protein engineering and dearth of trained personnel are hindering the market.

Key players operating in the protein engineering market are Agilent Technologies (U.S.), AB-Sciex (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).

Scope of the Report

  • The market does not provide country-level data for the European region
  • The market only includes medical applications of protein engineering

Particular

Scope

Region

  • North America (U.S. and Canada)
  • Europe
  • Asia (China, Japan, India and Rest of Asia)
  • RoW

Historical Years

2013

Base Year

2014

Estimated Year

2014

Forecast Period

2015–2020

Revenue Currency

USD ($)

Market Segmentation

This research report categorizes the protein engineering market on the basis of product, technology, end-user, and geographies.

Protein Engineering Market, by Product

  • Instruments
  • Reagents
  • Services and Software

Protein Engineering Market, by Technology

  • Rational Protein Design
  • Irrational Protein Design

Protein Engineering Market, by Protein Type

  • Monoclonal Antibodies
  • Insulin
  • Erythropoietin
  • Interferon
  • Colony Stimulating factor
  • Growth hormones
  • Coagulation Factor
  • Vaccines
  • Others (Interleukins, Follicle Stimulating Hormones, Enzyme Replacement)

Protein Engineering Market, by End-User

  • Academic Research Institutes
  • Pharmaceutical and& Biotechnology Companies
  • Contract Research Organizations

Protein Engineering Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
  • Asia
    • China
    • Japan
    • India
    • Rest of Asia
  • RoW (Rest of the World)

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Covered
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology
    2.1 Market Size Estimation
    2.2 Market Crackdown and Data Triangulation
           2.2.1 Key Data From Secondary Sources
           2.2.2 Key Data From Primary Sources
                    2.2.2.1 Key Industry Insights
           2.2.3 Assumptions

3 Executive Summary

4 Premium Insights
    4.1 Attractive Opportunities in the Protein Engineering Market
    4.2 Market, By End User
    4.3 Market, By Technology 
    4.4 Market, By Product
    4.5 Market Growth Opportunities, By Region 
    4.6 Lifecycle Analysis, By Region

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increase in Adoption of Protein-Based Drugs Over Non-Protein-Based Drugs
                    5.2.1.2 Reduction in Overall Timeline and Cost for Drug Discovery
                    5.2.1.3 High Prevalence Rate of Lifestyle Diseases
                    1.2.1.4 Growth in Funding for Protein Engineering
           5.2.2 Restraints
                    5.2.2.1 Expensive and High Maintenance Tools and Instruments Used in Protein Engineering
           5.2.3 Opportunities
                    5.2.3.1 Significant Growth Prospects in Developing Countries
                    5.2.3.2 Protein Therapy as an Alternative to Gene Therapy
                    5.2.3.3 Top-Selling Biologics Drugs Going Off–Patent in the Near Future
           5.2.4 Challenges
                    5.2.4.1 Need for Qualified Researchers and Mandatory Training in Protein Engineering Increases Cost of Process
           5.2.5 Winning Imperatives
                    5.2.5.1 Site-Directed Mutagenesis is A Breakthrough  Technology Augmenting the Growth of the Protein Engineering Market

6 Industry Insights
    6.1 Introduction
    6.2 Supply Chain Analysis
           6.2.1 Key Influencers
    6.3 Porter’s Five Forces Analysis
           6.3.1 Threat From New Entrants
           6.3.2 Threat From Substitutes
           6.3.3 Bargaining Power of Buyers
           6.3.4 Bargaining Power of Suppliers
           6.3.5 Intensity of Rivalry
    6.5 Strategic Benchmarking
           6.5.1 New Product Launches

7 Protein Engineering Market, By Product
    7.1 Introduction
    7.2 Instruments 
    7.3 Reagents
    7.4 Services & Software

8 Protein Engineering Market, By Technology
    8.1 Introduction
    8.2 Rational Protein Design
    8.2 Irrational Protein Design

9 Protein Engineering Market, By Protein Type
    9.1 Introduction
    9.2 Monoclonal Antibodies
    9.3 Insulin
    9.4 Erythropoietin
    9.5 Interferon
    9.6 Colony Stimulating Factor
    9.7 Growth Hormones
    9.8 Coagulation Factor
    9.9 Vaccines
    9.10 Others

10 Protein Engineering Market, By End User
     10.1 Introduction
     10.2 Academic Research Institutes
     10.3 Pharmaceutical & Biotechnology Companies
     10.4 Contract Research Organizations

11 Geographic Analysis
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
     11.4 Asia-Pacific
             11.4.1 China
             11.4.2 India
             11.4.3 Japan
             11.4.4 Rest of Asia (ROA)
     11.5 Rest of the World (ROW)

12 Competitive Landscape
     11.1 Overview
     11.2 Battle for Market Share: New Product Launches Was the Key Strategy
     11.3 New Product Launches
     11.4 Agreements, Partnerships, and Collaborations
     11.5 Expansions
     11.6 Acquisitions

13 Company Profile
     12.1 Agilent Technologies, Inc
             12.1.1 Business Overview
             12.1.2 Product Portfolio
             12.1.3 Key Strategy
             12.1.4 Recent Developments
     12.2 Bio-Rad Laboratories, Inc
             12.2.1 Business Overview
             12.2.2 Product Portfolio
             12.2.3 Key Strategy
             12.2.4 Recent Developments
     12.3 Bruker Corporation
             12.3.1 Business Overview
             12.3.2 Product Portfolio
             12.3.3 Key Strategy
             12.3.4 Recent Developments
             12.3.5 SWOT Analysis
             12.3.6 MNM View
     12.4 Danaher Corporation
             12.4.1 Business Overview
             12.4.2 Products & Services
             12.4.3 Key Strategy
             12.4.4 Recent Developments
     12.5 General Electric 
             12.5.1 Business Overview
             12.5.2 Product Portfolio
             12.5.3 Key Strategy
             12.5.4 Recent Developments
     12.6 Perkinelmer, Inc
             12.6.1 Products & Services
             12.6.2 Key Strategy
             12.6.3 Recent Developments
     12.7 Genscripts Usa, Inc.
             12.7.1 Business Overview
             12.7.2 Key Strategy
             12.7.3 Recent Developments
     12.8 Sigma-Aldrich Corporation
             12.8.1 Business Overview
             12.8.2 Product Portfolio
             12.8.3 Key Strategy
             12.8.4 Recent Developments
     12.9 Thermo Fisher Scientific
             12.9.1 Business Overview
             12.9.2 Product Portfolio
             12.9.3 Key Strategy
             12.9.4 Recent Developments
     12.1 Waters Corporation
             12.10.1 Business Overview
             12.10.2 Product Portfolio
             12.10.3 Key Strategy
             12.10.4 Recent Developments

14 Appendix
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports

Table Of Content (AVAILABLE CUSTOMIZATION)

1. Protein Engineering Market, By Region
1.1. Europe
1.1.1. U.K
1.1.2. France
1.1.3. Spain
1.1.4. Italy
1.1.5. Germany
1.1.6. Rest Of Europe (Roe)

2. Protein Engineering Market, By Protein Type
2.1. Others
2.1.1. Enzymes
2.1.2. Interleukins
2.1.3. Thrombolytics
2.1.4. Bone Morphogenetic Proteins
2.1.5. Others

3. Protein Engineering Market, By Product (Volume)
3.1. Instruments
3.2. Reagents And Consumables

4. Company Profiles
(Additional 5 Company Profiles Would Be Provided For The Players Who Have Substantial Share In Protein Engineering Market)

List of Tables (100 Tables)

Table 1 Protein Engineering Market Size, By Technology, 2013–2020 ($Million)
Table 2 Rational Protein Design Market Size, By Region, 2013–2020 ($Million)
Table 3 North America: Rational Protein Design Market Size, By Country, 2013–2020 ($Million)
Table 4 Asia: Rational Protein Design Market Size, By Country, 2013–2020 ($Million)
Table 5 Irrational Protein Design Market Size, By Region, 2013–2020 ($Million)
Table 6 North America: Irrational Protein Design Market Size, By Country, 2013–2020 ($Million)
Table 7 Asia: Irrational Protein Design Market Size, By Country, 2013–2020 ($Million)
Table 8 Market Size, By Product, 2013–2020 ($Million)
Table 9 Market Size for Instruments, By Region, 2013–2020 ($Million)
Table 10 North America: Market Size for Instruments, By Country, 2013–2020 ($Million)
Table 11 Asia: Market Size for Instruments, By Country/Region, 2013–2020 ($Million)
Table 12 Market Size for Reagents, By Region, 2013–2020 ($Million)
Table 13 North America: Market Size for Reagents, By Country, 2013–2020 ($Million)
Table 14 Asia: Market Size for Reagents, By Country/Region, 2013–2020 ($Million)
Table 15 Market Size for Services and Software, By Region, 2013–2020 ($Million)
Table 16 North America: Market Size for Services and Software, By Country, 2013–2020 ($Million)
Table 17 Asia: Market Size for Services and Software, By Country/Region, 2013–2020 ($Million)
Table 18 Market Size, By Protein Type, 2013–2020 ($Million)
Table 19 Monoclonal Antibodies Market Size, By Region, 2013–2020 ($Million)
Table 20 North America: Monoclonal Antibodies Market Size, By Country, 2013–2020 ($Million)
Table 21 Asia: Monoclonal Antibodies Market Size, By Country, 2013–2020 ($Million)
Table 22 Insulin Market Size, By Region, 2013–2020 ($Million)
Table 23 North America: Insulin Market Size, By Country, 2013–2020 ($Million)
Table 24 Asia: Insulin Market Size, By Country, 2013–2020 ($Million)
Table 26 Erythropoietin Market Size, By Region, 2013–2020 ($Million)
Table 27 Asia: Erythropoietin Market Size, By Country, 2013–2020 ($Million)
Table 28 Interferons Market Size, By Region, 2013–2020 ($Million)
Table 29 North America: Interferons Market Size, By Country, 2013–2020 ($Million)
Table 30 Asia: Interferons Market Size, By Country, 2013–2020 ($Million)
Table 31 Colony Stimulating Factors Market Size, By Region, 2013–2020 ($Million)
Table 32 North America: Colony Stimulating Factors Market Size, By Country, 2013–2020 ($Million)
Table 33 Asia: Colony Stimulating Factor Market Size, By Country, 2013–2020 ($Million)
Table 34 Growth Hormones Market Size, By Region, 2013–2020 ($Million)
Table 35 North America: Growth Hormones Market Size, By Country, 2013–2020 ($Million)
Table 36 Asia: Growth Hormones Market Size, By Country, 2013–2020 ($Million)
Table 37 Coagulation Factors Market Size, By Region, 2013–2020 ($Million)
Table 38 North America: Coagulation Factors Market Size, By Country, 2013–2020 ($Million)
Table 39 Asia: Coagulation Factors Market Size, By Country, 2013–2020 ($Million)
Table 40 Vaccines Market Size, By Region, 2013–2020 ($Million)
Table 41 North America: Vaccines Market Size, By Country, 2013–2020 ($Million)
Table 42 Asia: Vaccines Market Size, By Country, 2013–2020 ($Million)
Table 43 Other Proteins Market Size, By Region, 2013–2020 ($Million)
Table 44 North America: Other Proteins Market Size, By Country, 2013–2020 ($Million)
Table 45 Asia: Other Proteins Market Size, By Country, 2013–2020 ($Million)
Table 46 Global Market Size, By End User, 2013–2020 ($Million)
Table 47 Market Size for Academic Research Institutes, By Region, 2013–2020 ($Million)
Table 48 North America: Market Size for Academic Research Institutes, By Country, 2013–2020 ($Million)
Table 49 Asia: Market Size for Academic Research Institutes, By Country/Region, 2013–2020 ($Million)
Table 50 Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2013–2020 ($Million)
Table 51 North America: Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2013–2020 ($Million)
Table 52 Asian Market Size for Pharmaceutical and Biotechnology Companies, By Country/Region, 2013–2020 ($Million)
Table 53 Market Size for CROS, By Region, 2013–2020 ($Million)
Table 54 North America: Market Size for CROS, By Country, 2013–2020 ($Million)
Table 55 Asia: Market Size for Pharmaceutical and Biotechnology Companies, By Country/Region, 2013–2020 ($Million))
Table 56 Protein Engineering Market Size, By Region, 2013–2020 ($Million))
Table 57 North America: Market Size, By Country, 2013–2020 ($Million)
Table 58 North America: Market Size, By Product, 2013–2020 ($Million)
Table 59 North America: Market Size, By Technology, 2013–2020 ($Million))
Table 60 North America: Market Size, By Protein Type, 2013–2020 ($Million)
Table 61 North America: Market Size, By End User, 2013–2020
Table 62 U.S.: Market Size, By Product, 2013–2020 ($Million)
Table 63 U.S.: Market Size, By Technology, 2013–2020 ($Million)
Table 64 U.S.: Market Size, By Protein Type, 2013–2020 ($Million)
Table 65 U.S.: Market Size, By End User, 2013–2020 ($Million)
Table 66 Canada: Market Size, By Product, 2013–2020 ($Million)
Table 67 Canada: Market Size, By Technology, 2013–2020 ($Million)
Table 68 Canada: Market Size, By Protein Type, 2013–2020 ($Million)
Table 69 Canada: Market Size, By End User, 2013–2020 ($Million)
Table 70 Europe: Market Size, By Product, 2013–2020 ($Million)
Table 71 Europe: Market Size, By Technology, 2013–2020 ($Million)
Table 72 Europe: Market Size, By Protein Type, 2013–2020 ($Million)
Table 73 Europe: Market Size, By End User, 2013–2020 ($Million)
Table 74 Asia: Protein Engineering  Market Size, By Country, 2013–2020 ($Million))
Table 75 Asia: Protein Engineering Market Size, By Product, 2013–2020 ($Million)
Table 76 Asia: Market Size, By Technology, 2013–2020 ($Million)
Table 77 Asia: Market Size, By Protein Type, 2013–2020 ($Million)
Table 78 Asia: Protein Engineering Market Size, By End User, 2013–2020
Table 79 China: Protein Engineering Market Size, By Product, 2013–2020 ($Million)
Table 80 China: Market Size, By Technology, 2013–2020 ($Million)
Table 81 China: Market Size, By Protein Type, 2013–2020 ($Million)
Table 82 China: Protein Engineering Market Size, By End User, 2013–2020 ($Million)
Table 83 India: Market Size, By Product, 2013–2020 ($Million)
Table 84 India: Market Size, By Technology, 2013–2020 ($Million)
Table 85 India: Market Size, By Protein Type, 2013–2020 ($Million)
Table 86 Japan: Protein Engineering Market Size, By Product, 2013–2020 ($Million)
Table 87 Japan: Protein Engineering Market Size, By Technology, 2013–2020 ($Million)
Table 88 Japan: Protein Engineering Market Size, By Protein Type, 2013–2020 ($Million)
Table 89 Japan: Protein Engineering Market Size, By End User, 2013–2020 ($Million)
Table 90 ROA: Protein Engineering Market Size, By Product, 2013–2020 ($Million)
Table 91 ROA: Market Size, By Technology, 2013–2020 ($Million)
Table 92 ROA: Market Size, By Protein Type, 2013–2020 ($Million)
Table 93 ROW: Protein Engineering Market Size, By Product, 2013–2020 ($Million)
Table 94 ROW: Protein Engineering Market Size, By Technology, 2013–2020 ($Million)
Table 95 ROW: Protein Engineering Market Size, By Protein Type, 2013–2020 ($Million
Table 96 ROW: Market Size, By End User, 2013–2020 ($Million)
Table 97 New Product Launches, 2012–2015
Table 98 Agreements, Partnerships, and Collaborations, 2011–2015
Table 99 Expansions 2012-2015
Table 100 Acquisitions, 2012–2015
 
 
List of Figures (53 Figures)
 
Figure 1 Research Methodology
Figure 2 Market Size Estimation
Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Data Triangulation Methodology
Figure 5 Protein Engineering Market Snapshot (2014 vs. 2020
Figure 6 Pharmaceutical and Biotechnology Companies Will Continue to Dominate the Protein Engineering Market During the Forecast Period
Figure 7 Protein Engineering Technology Market Snapshot (2014 vs. 2019): Rational Design to Witness Highest Growth Rate in the Next Five Years
Figure 8 Asia Expected to Be the Fastest-Growing Market During the Forecast Period
Figure 9 New Product Launches Was the Major Strategy Adopted By Industry Players
Figure 10 Market Growth Will Be Driven By Increasing Adoption of Biologics
Figure 11 Pharmaceutical and Biotechnology Companies Accounted for the Largest Share in 2014
Figure 12 Rational Protein Design is Expected to Dominate the Technology Market During the Forecast Period
Figure 13 Software and Services Segment Holds Lucrative Growth Opportunities
Figure 14 Asia to Witness the Highest Grow Rate From 2015 to 2020
Figure 15 Asia Holds Lucrative Growth Opportunities
Figure 16 Protein Engineering Market: Technological Evolution
Figure 17 Protein Engineering Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Direct Distribution—Strategy Preferred By Prominent Companies
Figure 19 Requirement of High Capital Investment to Restrict Entry of New Players
Figure 20 Market Leaders Adopted the Organic Growth Strategy of New Product Launches
Figure 21 Instruments Expected to Be the Largest Segment in Forecast Period
Figure 22 North America Will Continue to Lead Protein Engineering Instruments Market for the Forecast Period
Figure 23 Asian Reagents Segment to Show Fastest Growth
Figure 24 Snapshot: Rational and Irrational Protein Design
Figure 25 Rational Protein Design Segment Will Continue to Dominate the Market in the Forecast Period
Figure 26 North America Accounted for the Largest Share in the Rational Protein Design Market
Figure 27 Monoclonal Antibodies Will Continue to Dominate the Market in the Forecast Period
Figure 28 North America Accounted for the Largest Share in the Insulin Market
Figure 30 North America Commanded the Largest Share of the Erythropoietin Market in 2014
Figure 31 Asia is the Fastest Growing Segment of the CSF Market
Figure 32 Asia is the Fastest Growing Market for the Forecast Period
Figure 33 North America Commanded the Largest Share of Others Market in 2014
Figure 34 Broad End-User Base of Protein Engineering
Figure 35 North America Dominates the Protein Engineering Market for Academic Research Institutes
Figure 36 Asia Will Be the Fastest-Growing Market By 2020
Figure 37 Asia An Attractive Destination for Protein Engineering
Figure 38 Government Funding and Technology Advancements To drive Demand for Protein Engineering
Figure 39 Rational Design Segment Will Continue to Lead the Protein Engineering Technologies Market in the U.S.
Figure 40 Rational Protein Design Technology Segment Expected to Grow at the Highest Rate From 2015 to 2020
Figure 41 European Protein Engineering Market Snapshot
Figure 42 Japan Will Continue to Dominate the Asian Protein Engineering Market in the Next Five Years
Figure 43 Instruments Segment  to Witness the Highest Growth in the ROW Region
Figure 44 Geographic Revenue Mix of Top 4 Market Players
Figure 45 Agilent Technologies, Inc.: Company Snapshot
Figure 46 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 47 Bruker Corporation: Company Snapshot
Figure 48 Danahar Corporation: Company Snapshot
Figure 49 General Electric: Company Snapshot
Figure 50 Genscript Usa, Inc.: Company Snapshot
Figure 51 Perkinelmer, Inc.: Company Snapshot
Figure 52 Sigma-Aldrich Corporation: Company Snapshot
Figure 53 Thermo Fisher Scientific, Inc.: Company Snapshot

The protein engineering market is expected to grow at a double–digit CAGR of 15.7% to reach $1,463.0 million by 2020 from $705.5 million in 2015. Major factors fueling market growth are the increase in adoption of protein drugs over non-protein drugs, high prevalence rate of lifestyle diseases, growth in funding for protein engineering, and reduction in overall timeline and cost for drug discovery. However, expensive and high maintenance tools and instruments used in protein engineering and dearth of trained personnel are restricting the growth of the market.

This market is broadly segmented into instrument, reagent and services and software, by product. On the basis of technology the market is segmented into rational protein design, and irrational protein design. Rational protein design emerged as highly adopted technology in protein engineering market in 2014.

Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies is the largest as well as fastest growing segment of the protein engineering protein type market.

Based on end user, the protein engineering market is broadly classified into academic research institutes, pharmaceutical and biotechnology companies and contract research organizations. Pharmaceutical and biotechnology companies is the largest and fastest-growing end user segment. The high growth rate of this market can be attributed to technological advancements in protein engineering and the increase in R&D budgets in the pharmaceutical sector.

Geographically, this market is dominated by North America, followed by Europe. Asia is expected to be the fastest growing region during the forecast period.

Key players operating in this market are AB-Sciex (U.S.),  Agilent Technologies (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), , GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).

Protein Engineering Market Scenario, by Product, 2014

Protein Engineering Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports